Atomistry » Chlorine » PDB 5luj-5lzm » 5lz9
Atomistry »
  Chlorine »
    PDB 5luj-5lzm »
      5lz9 »

Chlorine in PDB 5lz9: Fragment-Based Inhibitors of Lipoprotein Associated Phospholipase A2

Enzymatic activity of Fragment-Based Inhibitors of Lipoprotein Associated Phospholipase A2

All present enzymatic activity of Fragment-Based Inhibitors of Lipoprotein Associated Phospholipase A2:
3.1.1.47;

Protein crystallography data

The structure of Fragment-Based Inhibitors of Lipoprotein Associated Phospholipase A2, PDB code: 5lz9 was solved by A.Woolford, P.Day, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 44.39 / 2.06
Space group C 1 2 1
Cell size a, b, c (Å), α, β, γ (°) 100.044, 91.332, 51.357, 90.00, 111.97, 90.00
R / Rfree (%) 18.3 / 23.3

Other elements in 5lz9:

The structure of Fragment-Based Inhibitors of Lipoprotein Associated Phospholipase A2 also contains other interesting chemical elements:

Fluorine (F) 1 atom
Sodium (Na) 1 atom

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Fragment-Based Inhibitors of Lipoprotein Associated Phospholipase A2 (pdb code 5lz9). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Fragment-Based Inhibitors of Lipoprotein Associated Phospholipase A2, PDB code: 5lz9:

Chlorine binding site 1 out of 1 in 5lz9

Go back to Chlorine Binding Sites List in 5lz9
Chlorine binding site 1 out of 1 in the Fragment-Based Inhibitors of Lipoprotein Associated Phospholipase A2


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Fragment-Based Inhibitors of Lipoprotein Associated Phospholipase A2 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl501

b:38.7
occ:1.00
N A:ALA326 3.2 46.1 1.0
CD A:PRO325 3.7 48.6 1.0
CB A:ALA326 3.7 44.9 1.0
N A:PRO325 3.8 46.9 1.0
CB A:PRO325 3.8 49.3 1.0
CD2 A:TYR324 3.9 44.3 1.0
CB A:TYR324 4.1 42.5 1.0
CA A:ALA326 4.1 45.5 1.0
CA A:PRO325 4.1 47.0 1.0
CG A:PRO325 4.1 50.4 1.0
C A:PRO325 4.1 47.2 1.0
C A:TYR324 4.3 43.3 1.0
CG A:TYR324 4.5 41.2 1.0
CA A:TYR324 4.8 43.7 1.0
CE2 A:TYR324 5.0 43.0 1.0
O A:TYR324 5.0 43.0 1.0

Reference:

A.J.Woolford, P.J.Day, V.Beneton, V.Berdini, J.E.Coyle, Y.Dudit, P.Grondin, P.Huet, L.Y.Lee, E.S.Manas, R.L.Mcmenamin, C.W.Murray, L.W.Page, V.K.Patel, F.Potvain, S.J.Rich, Y.Sang, D.O.Somers, L.Trottet, Z.Wan, X.Zhang. Fragment-Based Approach to the Development of An Orally Bioavailable Lactam Inhibitor of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2). J. Med. Chem. V. 59 10738 2016.
ISSN: ISSN 1520-4804
PubMed: 27933945
DOI: 10.1021/ACS.JMEDCHEM.6B01427
Page generated: Sat Jul 12 05:13:58 2025

Last articles

Cu in 1R1C
Cu in 1RJP
Cu in 1RJO
Cu in 1RCY
Cu in 1R5A
Cu in 1QLE
Cu in 1PU0
Cu in 1QHQ
Cu in 1QD0
Cu in 1QAL
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy